Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Ripple

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Seminars in Oncology|December 22, 1999
Drug development in prostate cancerG H Ripple, G Wilding
Clinical Lung Cancer|January 21, 2004
Pilot and safety trial of carboplatin, paclitaxel, and thalidomide in advanced non small-cell lung cancerJ J Merchant, K Kim, M P Mehta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I clinical trial of perillyl alcohol administered dailyG H Ripple, M N Gould, J A Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a dayG H Ripple, M N Gould, R Z Arzoomanian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2012
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinomaJ M Pipas, B I Zaki, M M McGowan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Seminars in Oncology|December 22, 1999
Drug development in prostate cancerG H Ripple, G Wilding
Clinical Lung Cancer|January 21, 2004
Pilot and safety trial of carboplatin, paclitaxel, and thalidomide in advanced non small-cell lung cancerJ J Merchant, K Kim, M P Mehta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I clinical trial of perillyl alcohol administered dailyG H Ripple, M N Gould, J A Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a dayG H Ripple, M N Gould, R Z Arzoomanian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2012
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinomaJ M Pipas, B I Zaki, M M McGowan, et al.
Pageof 1